臺北新聞熱綫

Zhuhai – The Chimelong ferry, jointly launched by China Merchants Cruises, Trip.com, and Chimelong Group, made its grand inaugural voyage on July 8 at Shenzhen Shekou Prince Bay Cruise Homeport. To better serve international travelers, the “Chimelong Ferry” simplifies the entire journey — from booking to arrival — by offering a seamless, high-quality travel experience through its “one-stop direct access + hassle-free service” model. This approach significantly enhances cross-border convenience, enabling tourists to reach and enjoy Hengqin Chimelong International Ocean Resort with ease, while promoting deeper integration of tourism and transportation across the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). Revamped End-to-End Services, Targeting Key Travel Pain Points For international visitors to Chimelong Resort in Hengqin, traditional inbound travel often comes with three main challenges: complicated travel routes, language barriers, and trouble handling luggage. Travelers flying via Hong Kong International Airport and heading to Guangdong usually need several transfers, which will be both time-consuming and exhausting. “Chimelong Ferry” has launched targeted solutions, pioneering an innovative model that builds on “one-stop direct access + hassle-free service” that redefines travel experiences through seamlessly connected journeys. The service offers a 2.5-hour convenient route from Hong Kong Airport to Hengqin Chimelong International Ocean Resort, spanning Hong Kong Airport → Shenzhen Shekou → Hengqin. This end-to-end route significantly save transfer time. Professional Chinese-English bilingual guides and clear signage are available throughout the journey, fully eliminating language barriers. Additionally, passengers can check luggage directly from Shekou Cruise Homeport to Chimelong-affiliated hotels in Hengqin, avoiding extra handling and enjoying a hassle-free trip. “Chimelong Ferry” has also upgraded services across the entire travel process: pre-departure, during the journey, and post-arrival. At the booking stage prior to departure, international travelers can conveniently purchase tickets online using major credit cards, with the platform supporting 24 languages to cater to a global audience. In addition, Trip.com offers exclusive deals for international visitors — including a 30% discount on double tickets for Chimelong’s three major resorts, and attractive hotel packages in Guangzhou and Hengqin such as “Buy 2 Adults, Get 2 Children Free.” International passengers taking the “Chimelong Ferry” can use dedicated check-in counters and immigration lanes, significantly speeding up clearance. At Shekou Cruise Homeport, the “Chimelong Ferry” VIP lounge allows passengers to complete hotel check-in and luggage drop-off in one go, eliminating transfer-related stress. The Ferry seamlessly integrates Chimelong’s iconic elements into its exterior and interior design. Upon arrival in Hengqin, passengers can board exclusive shuttle buses that take them directly to Hengqin Chimelong Resort. With convenient luggage transfer services and priority ride access, guests can jump straight into the adventure — enjoying a truly seamless and carefree experience from beginning to end. Deep Integration of “Transport + Tourism,” Building a New Travel Ecosystem Linking Hong Kong International Airport to Hengqin Chimelong International Ocean Resort, “Chimelong Ferry” is injecting transformative vitality into inbound tourism. Its 2.5-hour direct service, multilingual support, and seamless luggage handling system deliver an unparalleled travel experience for visitors. Its destination, Zhuhai Hengqin Chimelong International Ocean Resort, is a world-renowned tourist attraction. In June 2024, it was officially designated as a “National Tourist Resort.” This year, Hengqin Chimelong received two prestigious Thea Awards: one for the spectacle show “Chimelong Show,” and another for the marine theme park “Chimelong Spaceship.” The launch of  “Chimelong Ferry”  not only injects fresh vitality into the inbound tourism market but also helps position the GBA as a world-class tourism destination. With continuous service upgrades, this “golden corridor” is set to become a new window showcasing China’s tourism service standards. Media contact Brand Name: Chimelong International Travel Company Limited City, State, Country: Room 907, 9/F, Mirror Tower, No. 61 Mody Road, Tsim Sha Tsui East, Kowloon, Hong Kong Contact Person: Marketing Team Email: nancy.zhang@chimelong-int.com Tele: 400-883-0083 Website: https://www.chimelong.com

KUALA LUMPUR, MALAYSIA – July 25, 2025 – (SeaPRwire) – maxWin (https://maxwinofficial.com), a leading name in Asia’s digital gaming landscape, has secured the prestigious Honesty Award 2025, cementing its status as a standard-bearer for trust, integrity, and ethical conduct in the online entertainment industry. The Honesty Award, bestowed upon brands that consistently prioritize transparent operations and fair gaming practices, highlights maxWin’s unwavering commitment to player-first values in a market often clouded by uncertainty. This year’s recognition reflects maxWin’s dedication to straightforward policies, open communication, and a zero-tolerance stance on unfair play. “At maxWin, integrity is the foundation of everything we do,” said James Stapleton, CEO of maxWin. “This award is more than just an honor—it’s a reflection of our promise to put players first and to build a platform that stands up to scrutiny.” Championing Fair Play Across Southeast Asia While the region’s online gaming sector continues to evolve, maxWin has carved out a loyal following by focusing on ethical business conduct over empty promotional hype. The company’s industry-leading payout transparency, rigorous anti-fraud measures, and clearly defined withdrawal processes have made it a trusted choice for players across Malaysia, Singapore, Indonesia, and beyond. maxWin’s commitment to honesty is further demonstrated through regular independent audits, transparent bonus terms, and a customer support team trained to resolve issues quickly and fairly. The platform maintains a strict “no hidden fees” policy and provides players with detailed, easyto-understand information about every aspect of the gaming experience. Raising the Bar for the Industry As more players in Southeast Asia demand fair treatment and reliable platforms, maxWin’s Honesty Award serves as a milestone not just for the company, but for the entire industry. The recognition signals a growing appetite among players for transparent, responsible, and playerfocused operators. Looking Forward: maxWin’s Next Steps Building on the momentum of the Honesty Award, maxWin will continue to advance player protection and responsible gaming. Upcoming features include enhanced educational resources, expanded self-exclusion options, and improved tools for tracking spending and setting personal limits. “Our vision is to create a gaming environment where trust comes first,” added James Stapleton. “With this award, we’re inspired to push even further—delivering innovation, security, and transparency every step of the way.” About maxWin maxWin is an established online gaming platform serving Southeast Asia, offering a diverse portfolio of online gaming and e-sports games. Under the leadership of CEO James Stapleton, maxWin is committed to setting the highest standards in fair play, customer transparency, and responsible gaming. Discover more at maxWin‘s official website. Social Links Facebook: https://www.facebook.com/maXwin.Official88/ Instagram: https://www.instagram.com/maxwin.my/ YouTube: https://www.youtube.com/@maXwinofficial-88 Media contact Brand: MaxWin Contact: Media team Email: support@maxwinofficial.com Website: https://maxwinofficial.com

Seoul, South Korea – July 22, 2025 – (SeaPRwire) – Wearable fashion-tech brand Timeflik (CEO Kyung Sung-hyun, by Apposter Inc.) announced on the 25th that it has released an updated version of its app based on Wear OS 6, recently unveiled at Google I/O 2025. The key feature of this update is that users can now select the version of the Timeflik app optimized for their specific Watch OS version directly within the app. Developed in collaboration with Google’s Wear OS team over the past six months, the newly added Wear OS 6 version offers a more intuitive experience with an improved UI, faster navigation, and personalized recommendations. Existing users can access these features by updating the Timeflik app via Google Play. However, depending on their device’s Watch OS version, users must manually select either the existing or new version after updating. The new Wear OS 6 version is initially available for the latest devices such as the Galaxy Watch 8. Users of older models, including the Galaxy Watch 7 and Ultra series, will be able to access the update following Google’s scheduled OS rollout later this year. With this release, Timeflik now provides watch faces with the same functionality as those available on the Google Play Store. Users can freely customize colors, styles, and complications, all while enjoying a power-efficient design that balances performance and practicality. In addition, Timeflik is expanding collaborations with global designers featured on Google Play, allowing users to discover a wide variety of stylish watch faces easily within the app. To celebrate the update, Timeflik is offering all users free access to “In Your Room”, the follow-up to its bestselling watch face series “In My Room”. A special discounted subscription promotion is also underway, offering unlimited access to all watch faces. A Timeflik spokesperson stated, “With this update, we’re proud to offer optimized service across all Wear OS devices,” adding, “We will continue to strengthen our competitiveness in the global watch face market with differentiated content and cutting-edge technology.” About the Company Apposter Inc. (https://apposter.com/ ) is a tech company that has grown around smartwatch content platforms. Its flagship service, Timeflik, is a global watch face app with over 10 million cumulative downloads. The app offers more than 2 million free watch faces, a designer marketplace, and a wide range of customization options. Timeflik has been recognized for excellence with accolades such as Google Play’s Best Apps of the Year (2021), the Good Design Award, and the German Design Award (GDA 2023). Leveraging its technical expertise and design capabilities, Timeflik continues to lead the wearable content market. Media Contact Brand: Timeflik Contact: Sehee Park, Team Lead, E-commerce Division Email: psh@apposter.com Phone: +82 2-538-0333 Website: https://www.timeflik.com

Kuala Lumpur, July 23, 2025 — At the 24th International Architecture, Interior Design & Building Exhibition Malaysia (ARCHIDEX 2025), KELESI New Material Technology Co., Ltd., a professional Chinese manufacturer of acrylic solid surface materials, made a prominent appearance with its full product matrix and latest innovations. This exhibition not only serves as a window into KELESI’s 17 years of expertise in R&D and manufacturing, but also marks a strategic starting point for empowering the Southeast Asian construction market through innovative materials. KELESI showcased its core product lines and, for the first time in the Malaysian market, introduced two innovative products under its sub-brand LEGOU: the acrylic micron solid surface and the modified micron solid surface. Based on micron-level technology, these new materials drew strong interest from contractors, designers, and distributors due to their excellent performance, aesthetic appeal, and cost advantages. Acrylic Micron Solid Surface: Specially optimized for high-performance sink pressing applications, it offers outstanding thermoforming capabilities and remarkable cost-performance value. It effectively overcomes the limitations of traditional composite materials in producing customized integrated sinks, offering a high-quality yet cost-efficient solution for kitchen and bathroom design. Modified Micron Solid Surface: Made from micronized natural powder, it features a smooth and delicate surface with a warm, soft touch. It delivers exceptional stain and bacterial resistance and meets food contact safety standards. Its broad applicability spans kitchens, bathrooms, and commercial offices, making it especially well-suited for engineering projects requiring both cost control and premium quality. The Southeast Asian construction market is in a phase of rapid growth, with strong demand for green building materials, efficient delivery, and cost management. At this exhibition, KELESI not only presented cutting-edge material technologies, but also engaged in in-depth exchanges with buyers and designers from Malaysia, Singapore, and Indonesia to better understand local market demands. According to the head of KELESI’s International Business Division, LEGOU will serve as the anchor brand, supported by KELESI’s robust integrated R&D–manufacturing–service system, anchored in its Shanghai operation center and smart production base in Weifang, Shandong. Through ongoing technological innovation and localized strategies, KELESI aims to offer Southeast Asian partners a competitive product portfolio, flexible color customization, and responsive service systems—jointly advancing the regional building materials industry toward enhanced aesthetics, sustainability, and economic efficiency. As a “Global Innovator in Solid Surface Materials,” KELESI will continue to drive product upgrades through technological innovation and remain committed to delivering high-quality, high-value material solutions for architectural spaces worldwide—empowering new possibilities in modern construction. Company Name: Shandong KELESI New Material Technology Co., Ltd. Website: www.sdkelesi.com Telephone: 189 6423 3651 Contact: Kimi Han Email Address: kimi@shkelesi.com

Seoul, South Korea – July 21, 2025 – (SeaPRwire) – S.BIOMEDICS announced encouraging one-year post-transplant results from Phase 1/2a clinical trial evaluating A9-DPC cell therapy for Parkinson’s disease. The data demonstrate a favorable safety and efficacy profile of A9-DPC in 12 participants at 12 months compared to baseline. Participants were divided equally into a low-dose group (3.15 million cells) and a high-dose group (6.30 million cells). A9-DPC (TED-A9) consists of high-purity ventral midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs) under rigorous GMP conditions. A total of 12 participants received bilateral putamen transplantation with either a low-dose (3.15 million cells; n = 6) or a high-dose (6.30 million cells; n = 6) of A9-DPC, with the last participant receiving treatment in February 2024. At 12 months, the safety profile was favorable, with no tumorigenesis, overgrowth of transplanted cells, ectopic cell migration, or immune-mediated inflammation observed. Clinical improvements were observed, along with evidence of cell survival and engraftment at the 12-month follow-up. Increased dopamine transporter (DAT) signals in putamen, measured by [18F]FP-CIT PET, correlated with the observed improvements of motor function. The MDS-UPDRS Part III (off) score, a standard scale for assessing motor symptom severity in Parkinson’s disease, showed a mean decrease (improvement) of 12.7 points in the low-dose group and 15.5 points in the high-dose group at 12 months compared to baseline. There were also improvements in MDS-UPDRS Part I, II and IV scores. The MDS-UPDRS Total (off) score showed mean improvements of 29.0 points and 34.7 points in the low- and high-dose groups, respectively. Clinical improvements were further supported by changes in the Hoehn and Yahr stage, an ordinal scale categorizing disease severity based on motor function. On average, low-dose recipients improved (decreased) from stage 3.7 to 2.7, while high-dose recipients demonstrated a greater improvement from stage 3.8 to 2.2. A9-DPC also demonstrated favorable outcomes in other assessments, including the Non-Motor Symptoms Scale (NMSS), the Parkinson’s Disease Questionnaire-39 (PDQ-39) and the Schwab and England Activities of Daily Living Scale (SEADL). NMSS score improved by 31.7 points in the low-dose group and by 35.8 points in the high-dose group. [18F]FP-CIT PET imaging showed an overall increase in putamen DAT signals, with greater increases observed in the high-dose group, providing additional evidence for the underlying mechanism of action. Notably, there was a statistically significant correlation between improvements in MDS-UPDRS Part III (off) scores and increased DAT signal in the posterior dorsal putamen, supporting the hypothesis of synaptic restoration through engrafted cells. In terms of safety, the safety profile remained favorable. No treatment-emergent adverse events (TEAEs) related to the transplanted cells were reported. Tumorigenesis, cell overgrowth, or ectopic cell migration was not observed. Most of TEAEs were mild to moderate. One participant experienced an asymptomatic mild hemorrhage, but no neurological abnormalities or other serious side effects were observed.  “Our data show a consistent positive trend throughout the study period, demonstrating the favorable safety and efficacy profiles. Importantly, increased DAT signals on PET imaging correlated with the observed behavioral recovery, which is very promising in terms of the mechanism of A9-DPC through neuroimaging.” said Prof. Dong-Wook Kim of Yonsei University College of Medicine and CTO of S.BIOMEDICS. “We will continue to present additional data through our ongoing study.” About A9-DPC and Phase 1/2a clinical trial A9-DPC (also called TED-A9) is an investigational cell therapy designed to replace ventral midbrain-specific dopaminergic neurons lost in patients with Parkinson’s disease. These ventral midbrain-specific dopaminergic cells are derived from hESCs (human embryonic stem cells) by exclusively utilizing small molecules under strict GMP conditions. A9-DPC represents a significant advancement in the field, offering highly purified dopaminergic cells derived from hESCs. Through a stereotactic surgical procedure, these hESC-derived dopaminergic progenitor (precursor) cells are transplanted into three segments of the putamen: the anterior, middle, and posterior sections, with three tracks per each putamen. Bilateral putamina were treated in a single surgical procedure, with cells injected at three points within each track. After transplantation, the progenitor cells are expected to mature into dopaminergic neurons, enhancing neural connectivity and restoring motor function in patients. The Phase 1/2a clinical trial enrolled 12 participants diagnosed with Parkinson’s disease for more than 5 years who exhibited motor complications such as wearing off, freezing of gait, or dyskinesia. Participants ranged from 50 to 75 years old. An initial low-dose cohort (3.15 million cells) of three patients was first enrolled to assess initial safety including dose-limiting toxicity (DLT) over three months. After confirming safety, an additional three patients received the high dose (6.30 million cells) for similar evaluation. With continued safety confirmation, three more patients were enrolled in each dose group, totaling 12 participants. The final participant received A9-DPC in February 2024. The primary objective of the Phase 1/2a trial is to evaluate the safety and exploratory efficacy for up to two years post-transplantation, with safety follow-up continuing for an additional three years. About S.BIOMEDICS Established in 2005, S.BIOMEDICS Co., Ltd. is a leading innovator in stem cell therapy, specializing in regenerative medicine powered by data-driven biology. Leveraging two core platform technologies, S.BIOMEDICS is currently advancing seven cell therapy programs targeting intractable diseases. Several of its lead candidates are now in clinical development, demonstrating the company’s leadership in advancing cell-based medicine:  A9-DPC (TED-A9): Ventral midbrain-specific dopaminergic progenitor cells derived from hESCs for Parkinson’s disease (Phase 1/2a) TED-N: PSA-NCAM-positive neural progenitor cells derived from hESCs for spinal cord injury (Phase 1/2a) FECS-Ad: 3D MSC spheroids for critical limb ischemia (completed Phase 1/2a) As the foremost authority and trailblazer in Parkinson’s disease treatment in South Korea, S.BIOMEDICS is setting the national standard for cell therapy innovation. More Information about the Phase 1/2a clinical trial for Parkinson’s disease is available at ClinicalTrials.gov (NCT05887466). For more information about S.BIOMEDICS, visit https://www.sbiomedics.com/. S.BIOMEDICS is listed on the Korea Exchange and is also the founder and controller of S.THEPHARM (www.sthepharm.com), a corporation specializing in anti-aging products such as HA-Filler. Media contact Brand: S.BIOMEDICS Contact: Sarang Kim Email: ksr7744@sbiomedics.com Website: https://www.sbiomedics.com

Singapore – July 21, 2025 – (SeaPRwire) – StealthMole, a rising player in cyber threat intelligence, has officially joined the Netskope Technology Partner Program, bringing a new layer of visibility into deep and dark web activity through a recently launched integration on the Netskope Cloud Exchange platform. The integration – StealthMole CRE – is designed to monitor the deep and dark web (DDW) for data leaks, with a primary emphasis on compromised credentials originating from malware-infected devices. Updated daily, the solution enables organizations to detect and respond to data breaches that may have gone unnoticed by conventional security solutions. The partnership arrives after a recent massive leak of 16 billion exposed login records. With growing concerns around credential theft and the increasing sophistication of cyberattacks, this partnership is expected to enhance the investigative capabilities of enterprises using Netskope’s platform. By providing near real-time intelligence on exposed credentials and related threat activity, StealthMole’s integration empowers security teams to take swift action to safeguard sensitive corporate information. “Credential breaches remain one of the most common – and damaging – threats to enterprise environments,” a StealthMole spokesperson commented. “By leveraging intelligence from the hidden corners of the internet, we’re equipping organizations with the context they need to defend against threats that rarely surface through standard monitoring tools.” Industry analysts note that this collaboration reflects a broader trend of cloud security platforms expanding their threat intelligence ecosystems through specialized partnerships. The StealthMole plugin is now accessible via the Netskope Cloud Exchange portal, offering users an immediate path to deeper insight into credential-based threats. As cyber threats continue to evolve, partnerships like this are becoming critical in giving security teams the intelligence advantage they need to stay ahead. About StealthMole StealthMole is a global leader in deep and dark web threat intelligence, offering businesses and security teams the tools they need for proactive digital risk management. With a powerful cloud-based platform, StealthMole delivers real-time insights into compromised credentials, data leaks, and cyber threats, empowering companies to stay ahead of evolving risks.Media contact Brand: StealthMole Contact: StealthMole Support TeamEmail: support@stealthmole.com Website: https://www.stealthmole.com

KUALA LUMPUR, MALAYSIA – July 21, 2025 – (SeaPRwire) – sureWin (https://surewin168.com), one of Southeast Asia’s fastest-growing online gaming platforms, has been honored with the Honesty Award 2025, recognizing its unwavering commitment to transparency, fair play, and customer first values in a competitive and rapidly evolving industry. The Honesty Award, presented annually to brands that demonstrate exceptional integrity and ethical business practices, is a rare and highly respected accolade in the global gaming space. sureWin’s achievement is a reflection of its clear terms of service, transparent payout structures, strict anti-fraud policies, and consistent user trust ratings over the past year. “This award isn’t just a trophy – it’s validation of our mission,” said James Smith, CEO of sureWin. “Since day one, we’ve built sureWin on a foundation of honesty and fairness. We’re proud to be recognized not for our size, but for how we treat our players.” Trust as a Competitive Edge In an industry often challenged by skepticism, sureWin has differentiated itself by focusing on reputation over hype. While many platforms compete with flashy bonuses and short-term gimmicks, sureWin has invested heavily in long-term trust – from verified game fairness to responsive customer support and secure financial transactions. sureWin also maintains a strict no-hidden-fees policy, provides clear withdrawal terms, and is one of the few platforms in the region to undergo third-party auditing for fairness in both casino and e-sports segments. Rising Standards in Southeast Asia The Honesty Award marks another milestone in sureWin’s growth journey, reflecting a growing demand for ethical platforms in emerging markets, especially across Malaysia, Thailand, Indonesia, and the Philippines, where sureWin continues to expand its user base. What’s Next for sureWin With this recognition, sureWin plans to double down on its core values by launching new initiatives focused on responsible gaming, player education, and enhanced transparency tools for users. “We don’t just want to be the most exciting platform – we want to be the most trusted,” added James. “This award is fuel for our next phase of growth.” About sureWin sureWin is a premier online gaming platform in Southeast Asia, offering a wide selection of casino, sports, fishing, e-sports, and lottery games. Under the leadership of CEO James Smith, sureWin remains committed to responsible gaming, fair play, and industry-leading transparency. Learn more at sureWin‘s Official Website. Media contact Brand: sureWin Contact: Media team Email: support@surewin168.com Website: https://surewin168.com

London, UK – July 18, 2025 – (SeaPRwire) – Virturo unveiled its next-generation trading technologies, reaffirming its leadership in premium CFD, Forex, and crypto brokerage for high-net-worth clients, at the July 2025 London Investor Summit. Virturo, the pioneering multi-asset broker, today reaffirms its commitment to high-net-worth clients by leveraging cutting-edge technology and AI-driven analytics. With its proprietary MarketFlow engine and AI-powered RiskGuard tools, Virturo delivers institutional-grade execution speed, robust security, and intelligent portfolio management across CFDs, Forex, and cryptocurrencies. A Unified Vision: Cutting-Edge Technology Meets Deep Expertise Since its launch, Virturo has focused on creating a world of opportunity for every client—whether opening a Basic Retail account or leveraging our VIP Professional tier. Through our proprietary MarketFlow engine, traders gain access to deep liquidity across CFDs, Forex, and cryptocurrencies, fractional positions on blue-chip equities, and algorithm-driven order execution that adapts in real time to market conditions. Beyond technology, Virturo’s dedicated team of Investment Specialists goes the extra mile: hosting one-on-one portfolio reviews, delivering bespoke market insights, and tailoring risk parameters to each individual’s objectives. From interactive webinars on emerging asset classes to around-the-clock chat support, we ensure that every investor—regardless of account size—benefits from institutional-grade tools, personalized guidance, and a seamless trading experience. MarketFlow Engine: Sub-millisecond execution across 3,000+ CFDs—including Equities, Forex, Indices, Commodities, and Cryptocurrencies—powered by ultra-low-latency feeds and intelligent order-routing. CryptoVault Security: Multi-signature, air-gapped cold-storage for all digital assets, with real-time monitoring to protect against market extremes. RiskGuard Suite: Configurable stop-loss, take-profit, trailing-stop, and live volatility analytics, combined with detailed margin and exposure reports. GDPR & Regulatory Compliance: Full adherence to GDPR protocols, encrypted data storage, client data rights, plus compliance with MiFID II and global financial standards. Client funds are held in segregated accounts with protection up to €85,000 per account. Client Support & Education: A comprehensive learning library, one-on-one strategy sessions, and 24/5 live-chat and phone support ensure that both retail and institutional investors receive personalized guidance. These features have made Virturo a top choice in Virturo reviews and positioned the company as a leading virturo broker: https://virturo.com/trading-accounts/ for sophisticated traders worldwide. A Platform Built for Every Trader Virturo offers access to 3,000+ instruments—from major and exotic Forex pairs to global stock CFDs, indices, commodities, and cryptocurrencies—all through a single, unified interface. Whether you’re speculating on oil price swings, hedging equity exposure, or capitalizing on Bitcoin’s momentum, our platform delivers ultra-tight spreads, sub-0.04-second execution, and transparent pricing you can depend on. Five Tailored Account Tiers To ensure every client has the precise tools and service level they need, Virturo has designed five progressive account tiers: Basic ($500 minimum deposit): Entry-level leverage and spreads, core market-analysis tools, our weekly market newsletter, and full access to educational resources. Prime ($2,500 minimum deposit): Improved spreads and commissions, enhanced leverage, unlimited educational content, and your own dedicated Investment Specialist. Apex ($25,000 minimum deposit): Market-grade spreads, maximum leverage, tailored commissions, exclusive analyst sessions, priority support, and premier-events access. Alpha ($100,000 minimum deposit): All Apex benefits plus zero commissions, guaranteed stop-loss protection, TradingView Pro integration, and on-demand market analysis. Zenith ($250,000 minimum deposit): The ultimate institutional-style experience: dedicated team support, IPO/ICO access, priority transactions, a loyalty package, and every Alpha feature. Each tier unlocks progressively deeper insights, customisable risk controls, and ever-more personalised service—ensuring that whether you’re just beginning or managing a complex portfolio, Virturo adapts to your needs. Virturo Academy: Education Meets Execution We believe that informed clients are successful clients. That’s why Virturo Academy offers: Structured Learning Paths on trading fundamentals, derivatives mechanics, and advanced algorithmic strategies Live Webinars & Workshops featuring senior analysts and guest experts Interactive Video Tutorials and step-by-step guides on our platform’s advanced tools Weekly Newsletters summarising key market events, economic indicators, and trading opportunities From basic charting techniques to sophisticated portfolio optimisation, Virturo Academy equips you with the knowledge to trade confidently. Market Outlook & Thought Leadership With Bitcoin recently surpassing $118,000—driven by record-setting institutional inflows and ETF developments—Alex cautions that “digital assets are no longer fringe; they’re essential for a diversified, inflation-hedged portfolio.” His insights echo Virturo’s latest analysis on how AI-driven tools and robust security are making crypto mainstream. Alex further advises: “Wealth isn’t just what you earn. It’s what your capital earns while you sleep.” Through Virturo’s advanced analytics and personalized strategies, clients can confidently participate in both established and emerging markets. About Virturo Virturo is a next-generation, award-winning multi-asset broker offering CFDs on Equities, Forex, Indices, Commodities, and Cryptocurrencies. Owned by Finastra LTD and operating under stringent GDPR and international financial regulations, Virturo empowers high-net-worth and institutional investors with cutting-edge technology, top-tier security, and a client-centric approach. For more information or to read the latest Virturo review, visit www.virturo.com or contact media@virturo.com. Social Links LinkedIn: https://www.linkedin.com/company/virturo-uk/ YouTube channel: https://www.youtube.com/@Virturo_Official Facebook: https://www.facebook.com/people/Virturo/61570821814759/ Media contact Brand: Virturo Contact: Media team Email: media@virturo.com Website: https://virturo.com

SHENZHEN, CHINA, July 16, 2025 – (ACN Newswire) – On the morning of 15 July 2025, China Medical System Holdings Limited (“CMS” or the “Group”) rang the ceremonial bell to mark its official listing on the Singapore Exchange Main Board (Stock Abbreviation: CMS, Stock Code: 8A8). Nearly one hundred representatives from global professional institutions, shareholders, business partners and employees gathered to witness this strategic moment. Following its successful IPO on the Hong Kong Stock Exchange Main Board in September 2010 , CMS advances with formidable momentum onto the international capital platform, which will attract funds focusing on Asia-Pacific investments and local capital in Southeast Asia to optimize the shareholder structure. This listing also marks a significant milestone for the Group to deepen roots in emerging markets and advance industrial internationalization strategy. At the listing ceremony, Chairman, Chief Executive Officer and President of CMS, Mr. Lam Kong stated: “The secondary listing in Singapore represents a crucial step in implementing CMS’s Asia-Pacific strategy, demonstrating our commitment to extending China’s market advantages across the entire APAC region while strengthening our presence in Southeast Asia and the Middle East. This move not only facilitates CMS’s comprehensive and sustainable development in Asia-Pacific markets, but also enhances our international influence and competitiveness, enabling us to serve broader patient populations with high-quality and affordable medication options.”         New CMS New Ascent Over the 33-year journey, CMS has continuously challenged and surpassed itself through three strategic transformations to adapt to the external ecosystem: evolving from “China’s largest CSO” (1992-2010), to “transition from CSO to Pharma” (2010-2018), and since 2018, gradually establishing three core strategies of “Innovation-driven, Specialty Breakthroughs and Industrial Internationalization” to promote the upgrading and iteration of “New CMS”, accumulating momentum for takeoff. CMS has established a comprehensive pharmaceutical product lifecycle management system, covering every stage from target identification to clinical development, product registration and commercialization. The Group focuses on FIC (First-in-Class) and BIC (Best-in-Class) innovative products, and has meticulously built a pipeline of approximately 40 innovative products with differentiated advantages, among which 5 innovative drugs have been approved and successfully commercialized in China. With the impact of VBP (Volume-Based Procurement) mostly cleared, CMS has entered a new cycle of high-quality and sustainable development driven by exclusive and innovative drugs. In specialty fields, the Group focuses on cardio-cerebrovascular, gastroenterology, ophthalmology and skin health, continuously deepening product portfolios and expert networks. Notably, the Group’s skin health business “DERMAVON” has emerged as a leader in its sector and is proposed for an independent listing on the Main Board of the Hong Kong Stock Exchange. A Pioneer in Industrial Internationalization Synergized Development Across the Entire “R&D, Manufacturing and Commercialization” Value Chain Since 2022, CMS has initiated its “Industrial Internationalization” strategy by extending the Group’s advantages and resources from the Chinese market to emerging markets. Utilizing Singapore as the strategic pivot, the Group has established a localized cluster comprising CMS R&D, PharmaGend, and Rxilient, achieving synergized development across the entire pharmaceutical value chain from R&D to production and commercialization, driving deeper and broader market expansion across the Asia-Pacific region. Internationalization of the Commercialization System: Rxilient serves as a platform for drug introduction, R&D and commercialization, operated by a professional and experienced localized team. Headquartered in Singapore, its business has expanded to 14 countries and regions including Malaysia, Thailand, Vietnam, the Philippines, Indonesia, and the Middle East, helping partners from China, the US, and Europe bring innovative drugs to emerging markets while introducing more high-quality and affordable treatment options to local markets. As of now, Rxilient has cumulatively submitted marketing applications for nearly 20 drugs and medical devices across Southeast Asia, the Middle East, Hong Kong, Macao and Taiwan, covering therapeutic areas such as dermatology, ophthalmology, oncology, autoimmune, and central nervous system. Internationalization of the Production System: PharmaGend, as an international CDMO platform based in Singapore, has a site spanning 30,000 square meters and is capable of manufacturing dosage forms such as tablets and capsules, with plans to expand production lines for injections, ointments, and nasal sprays. The factory has been certified by international authorities such as the FDA and the HSA, demonstrating its high-standard pharmaceutical manufacturing capabilities for global export . Structural factors including large population bases, healthcare insurance expansion and rising chronic disease burdens are transforming Southeast Asia, the Middle East and other emerging markets into new growth engines for the global pharmaceutical industry. Leveraging its integrated ecosystem, CMS is forming a novel model for Chinese pharmaceutical globalization – not only enabling incremental market conversion for its own products in emerging markets, but also providing global partners with a reliable one-stop solution, thereby generating additional growth momentum for the Group. Looking ahead, CMS will continue advancing its three core strategies to build the long-term value system of “New CMS”. By persistently enhancing accessibility to pharmaceutical innovation, CMS aims to benefit more patients, achieve sustainable healthy development, and deliver substantial value returns to investors. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd.

Kuala Lumpur, Malaysia – July 16, 2025 – (SeaPRwire) – maxWin Sports (https://maxwinofficial.com) today joins EBM-GIGA Racing Team as a Brand Partner and will be making the company’s motorsports debut in the Malaysian round of the AUTOBACS SUPER GT series held at the Petronas Sepang International Circuit. The sponsorship will also include selected rounds in the GT World Challenge Asia series. EBM-GIGA Racing Team will be spearheaded by Malaysian veteran racer Adrian D’Silva who will team up alongside Frenchman Dorian Boccolacci driving a Porsche 911 GT3R (992) in the GT300 Class this weekend. “Our Brand Partnership underlines maxWin Sports’ “Beyond Limits” which is an initiative to champion local Malaysian athletes,” said maxWin Sports’ Chief Executive Officer James Stapleton. “The goal is to empower Malaysian sports, to support Malaysia’s growing sports ecosystem and to make an impact in the local sports industry. We are aiming at inspiring the next generation of athletes in Malaysia. This aligns with maxWin’s broader mission of giving back to the community and fostering excellence beyond the digital space.” The 59-year-old D’Silva has 146 race starts to his credit and will be making his first appearance in SUPER GT. D’Silva’s career highlights include multiple appearances in the Asian Le Mans series and GT World Challenge Asia since 2010, and the Porsche Carrera Cup Asia, where he currently competes driving for Earl Bamber Motorsport. In 2021, he participated in the Spa-Francorchamps 24-Hour race with EBM Giga Racing, a 100 percent Malaysian-owned team. His achievements include a 3rd place finish at the Sepang 12 Hours in 2023, 4th in LMP3 at Asian Le Mans 2016, 4th in 2013 and 5th in 2014 at the Merdeka Endurance Race, and 3rd in the Asian Touring Car Series in 2009. Boccolacci meanwhile, joins the team with 239 race starts. Having successfully competed in a number of single-seater categories, winning races in GP3 and competing in FIA Formula 2 among other things, Boccolacci garnered success in GT cars, winning the V6 class at the 2020 24 Hours of Nurburgring and becoming the 2023 champion of the Porsche Carrera Cup France. The Autobacs SUPER GT returns to Malaysia after an absence of 12 years and will be staged for three years following the signing of an agreement between HARO Sports & Entertainment as the rights holder and promoter for the Malaysian round of the SUPER GT and the GT Association (GTA) as the rights holders for SUPER GT. The Malaysian round of the 2025 Autobacs SUPER GT race will be run over a distance of 300km and will be the third round of the 2025 race calendar which features a total of eight rounds – seven of which will take place in various circuits within Japan. Malaysia will remain as the ONLY overseas race for Super GT. The weekend concluded on a high note, with the EBM-GIGA Racing Team receiving the Best Team Performance Award, a recognition of their outstanding teamwork and competitive spirit throughout the event. About maxWin maxWin is one of the most trusted online casinos in Malaysia, holding authorization and licenses to operate in various countries such as Malaysia, Vietnam, Indonesia, Thailand, Cambodia, the Philippines, India, and Korea. As a Malaysia online casino featured among the best online casinos in Asia for 2024, we are recognized as one of the premier online casinos. About SUPER GT SUPER GT features the top manufacturers and drivers from Japan competing in the GT500 and GT300 Classes, attracting the best of Japanese manufacturers the likes of Nissan, Lexus, Toyota, Honda and Subaru, as well as continental marques that include Aston Martin, Lamborghini, Mercedes-Benz, Ferrari and BMW. Social Links Facebook: https://www.facebook.com/maXwin.Official88/ Instagram: https://www.instagram.com/maxwin.my/ YouTube: https://www.youtube.com/@maXwinofficial-88 Website: https://maxwinofficial.com

Dubai, UAE – July 14, 2025 – (SeaPRwire) – BlockBits, crypto futures trading platform, launch a new tool for advanced futures trading for higher potential returns with up to 200x leverage. As cryptocurrency markets mature and price swings become more extreme, active traders are increasingly turning to risk management strategies once reserved for traditional finance. One strategy gaining notable traction is hedging – protecting open positions by opening an opposing trade to balance potential losses. Unlike in stocks or commodities, hedging in crypto has only recently become practical for a wider range of traders. With the expansion of futures and perpetual contracts, traders can now offset price movements without selling or transferring their core holdings – a key advantage for long-term investors facing short-term market uncertainty. “For example, a trader holding a major crypto asset can hedge against sudden volatility by opening a short futures position. If the asset’s price drops, gains from the short can help offset losses on the original holding – providing greater peace of mind in unpredictable conditions”, – said in company. Recognizing this growing need, several crypto exchanges are now integrating built-in hedging tools. Features such as the ability to hold both long and short positions on the same pair within a single account are making once-complex strategies more accessible. This is especially important for traders using high leverage or delta-neutral approaches, where profits and losses on opposite positions can balance each other out. Such tools also reduce trading costs by avoiding the need to close and reopen positions repeatedly – a process that can rack up fees and slippage in fast-moving markets. A smoother, single-interface experience means traders can react faster to market shifts without interrupting their broader investment plans. One platform at the forefront of this trend is BlockBits, which has designed its trading environment specifically with hedging in mind. Users can open long and short positions simultaneously on the same pair, track risk and margin separately, and monitor real-time profit/loss and liquidation levels across both sides. In a recent example with the ETH/USDT pair, BlockBits traders were able to hold dual up to 200× leverage positions – a feature not always offered by other exchanges. By integrating hedging into the core trading interface, platforms like BlockBits are helping crypto derivatives mature – providing tools that cater to both aggressive trading and robust risk management. As more traders seek to balance exposure without sacrificing opportunity, such innovations are set to become a standard part of the crypto futures landscape. Contact information Brand: BlockBits Contact: Media team E-mail: info@blockbitstech.com  Website: https://blockbitstech.com/en

July 27, 2025 - (SeaPRwire) - According to a report published by "The Icons", Andy Lin, President of the World Taiwanese Chambers of Commerce Junior Chapter (WTCC JC), is redefining youth leadership for the global Chinese community. Through music, education, diplomacy, and social action, Lin exemplifies a new generation of cross-disciplinary cultural leaders, using his talents and compassion to build meaningful bridges between cultures and communities. A classically trained musician who moved to the U.S. at the age of 12, Lin earned a full scholarship to The Juilliard School and later obtained his Doctor of Musical Arts degree from Stony Brook University. As the first and only musician in Juilliard's history to perform concertos on both viola and erhu, his performances have graced the stages of Carnegie Hall and Lincoln Center, earning acclaim for fusing Eastern and Western musical traditions. But Lin's work transcends the concert stage. During the COVID-19 pandemic, he founded Farm2Manhattan, a platform connecting struggling farmers with city-based restaurants to address food distribution challenges. He also joined Concerts in Motion, performing for isolated elderly individuals and bringing music into the lives of those in need. His housing assistance platform, "NYC Housing Multiple-Choice Test," has supported over 16,000 international students in New York, helping them find safe and fair accommodation. In the field of education, Lin launched a music education center in Vietnam in 2025, combining local cultural roots with a global outlook. He is committed to nurturing emotional intelligence, empathy, and cultural awareness in children through music. "Music is not just about teaching skills," Lin affirms, "It's about awakening the soul and building the foundation for responsible global citizenship." His educational initiatives align closely with the United Nations Sustainable Development Goals (SDGs), earning him the U.S. Presidential Volunteer Service Gold Award in 2023. "Leadership is not about displaying power," Lin states. "It's about carrying responsibility. Real change doesn't require a perfect starting point - it begins the moment you choose to believe." From community development to international cultural diplomacy, Lin's work demonstrates that culture is not confined to ivory towers - it is a gentle but powerful force that engages directly with the world. His journey has become a new roadmap for young global Chinese leaders seeking to blend heritage with impact.